---
DrugClass: "[[Lower Respiratory System Drugs]]"
SubClass: "[[Leukotriene Modifiers and Immunomodulators]]"
DrugClassContra: "[[Leukotriene Modifiers and Immunomodulators#Contraindications]]"
DrugClassAdverse: "[[Leukotriene Modifiers and Immunomodulators#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
ThirdDrugClass: 
ThirdSubClass: 
BrandName: Xolair
Chapter: "31"
KindleLinkChap: "[Chapter 31](kindle://book?action=open&asin=B09FRF11YJ&location=16553)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases:
---
```smiles

```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Moderate to severe persistent asthma
150– 375 mg subcut every 2– 4 weeks

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Injection site reaction, anaphylaxis

### Interactions

`= this.ChemLink+this.file.name`

 